ShiraTronics

About ShiraTronics

ShiraTronics is dedicated to transforming the lives of individuals with Chronic Migraine by providing innovative solutions like neuromodulation therapy. Their mission is to restore quality of life and offer relief and hope to those affected by this debilitating condition.

Products & Services

Neuromodulation Therapy Device:A migraine-specific device placed beneath the skin, designed to provide continuous stimulation to targeted nerves associated with migraine, potentially relieving, interrupting, and preventing chronic migraine symptoms.

Specialties

Neuromodulation Therapy Chronic Migraine Treatment

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Series B T: - FT: Series B	A: 66000000 MR: - FA: $66 million FAN: 66000000	D: 2024-10-09 FD: 2024-10-09	9 investors

Series B Latest

2024-10-09

$66.0M

9 investors (Pro only)

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

R

Rob Binney

Chief Executive Officer

D

Debra Snowdale

Chief Financial Officer

A

Al Smythe

Vice President - R & D, Manufacturing, and Operations

F

Fred Ecklund

Vice President, Global Clinical Affairs

L

Leo Toay

Vice President of Regulatory

R

Ryan Lange

Director of Strategic Engagement

View 19 more team members with Pro

Unlock Full Team Directory

Recent News

ShiraTronics Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised